Biotech

Legend Biotech (NASDAQ: LEGN) reported financial results for the fourth quarter and full year ended December 31, 2025, highlighting continued…

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year increase driven by demand for…

Shares of Immunovant Inc (IMVT) Stock trading near the high end of its 52-week range Shares of Immunovant Inc (IMVT)…